Editorial commentary on the special issue of cancer research

References

[1] Wang P, Wei X, Qu X, et al. Potential clinical application of microRNAs in bladder cancer[J]. J Biomed Res, 2024, 38(4): 289-306. doi: 10.7555/JBR.37.20230245

[2] Gu Y, Wei K, Wang J. Phase separation and transcriptional regulation in cancer development[J]. J Biomed Res, 2024, 38(4): 307-321. doi: 10.7555/JBR.37.20230214

[3] Min P, Li Y, Wang C, et al. Cyclopeptide moroidin inhibits vasculogenic mimicry formed by glioblastoma cells via regulating β-catenin activation and EMT pathways[J]. J Biomed Res, 2024, 38(4): 322-333. doi: 10.7555/JBR.38.20240015

[4] Chen S, Wang X, Yang N, et al. p53 exerts anticancer effects by regulating enhancer formation and activity[J]. J Biomed Res, 2024, 38(4): 334-347. doi: 10.7555/JBR.37.20230206

[5] Guo M, Liu J, Zhang Y, et al. Genetic variants in C1GALT1 are associated with gastric cancer risk by influencing immune infiltration[J]. J Biomed Res, 2024, 38(4): 348-357. doi: 10.7555/JBR.37.20230161

[6] Cheng Y, Shi R, Ben S, et al. Genetic variation of circHIBADH enhances prostate cancer risk through regulating HNRNPA1-related RNA splicing[J]. J Biomed Res, 2024, 38(4): 358-368. doi: 10.7555/JBR.38.20240030

[7] Qian Z, Zhang Z, Cen L, et al. Mycobacterium smegmatis enhances shikonin-induced immunogenic cell death—an efficient in situ tumor vaccine strategy[J]. J Biomed Res, 2024, 38(4): 369-381. doi: 10.7555/JBR.38.20240049

[8] Hafiz MZ, Pan J, Gao Z, et al. Timosaponin AⅢ induces drug-metabolizing enzymes by activating constitutive androstane receptor (CAR) via dephosphorylation of the EGFR signaling pathway[J]. J Biomed Res, 2024, 38(4): 382-396. doi: 10.7555/JBR.38.20240055

[9] Tang J, Luo L, Bosco B, et al. Identification of cell surface markers for acute myeloid leukemia prognosis based on multi-model analysis[J]. J Biomed Res, 2024, 38(4): 397-412. doi: 10.7555/JBR.38.20240065